New diabetes clinical trial: Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

Published on: April 03, 2024 at 11:00PM
Conditions: Hypertriglyceridemia
Interventions: Drug: Plozasiran Injection; Drug: Placebo
Sponsors: Arrowhead Pharmaceuticals
Not yet recruiting
https://ift.tt/rbfTymK